TIBCO Software Inc. has announced that Biogemma, a European leader in plant biotechnologies for the agricultural sector, has selected TIBCO Spotfire® 3.1 to move beyond transcriptomic analyses and ...
On September 9, 2025, Altesa BioSciences announced a partnership with bioMérieux to use the BIOFIRE SPOTFIRE respiratory diagnostic platform as the primary point-of-care tool in its upcoming Phase 2B ...
Spotfire, Inc. has announced DecisionSite® for Microarray Analysis (DSMA), which gives drug makers a competitive advantage in quickly and accurately identifying potential drug targets. DSMA, available ...
Over 25,000 users in close to 1,000 organizations around the world use Spotfire DecisionSite to drive confident decision-making by quickly and easily spotting trends, outliers and unanticipated ...
PerkinElmer and Tibco Software inked a strategic alliance through which PerkinElmer has exclusively licensed Tibco’s Spotfire® analytics and data discovery platform for specific scientific R&D markets ...
In clinical, application authors in Spotfire regularly use SAS to extract data and prepare it and then do an initial analysis of that data in SAS. Now with Spotfire 4.5, those same clinicians can ...
Dr. Chris Hillman, Global AI Lead at Teradata, joins eSpeaks to explore why open data ecosystems are becoming essential for enterprise AI success. In this episode, he breaks down how openness — in ...
Spotfire was one of the early pioneers of data visualization that TIBCO Software acquired way back in 2007. As such, TIBCO Spotfire continues to enjoy a loyal base of users of a data visualization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback